Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. (Q45882036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Gounis MJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Spiga MG

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Graham RM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wilson A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lieber BB

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wakhloo AK

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Webster KA

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

762-771

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

Critical limb ischemia: nothing to give at the office?

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Therapeutic angiogenesis: a complex problem requiring a sophisticated approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Angiogenesis of the heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Time course of arteriogenesis following femoral artery occlusion in the rabbit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Molecular switches for regulating therapeutic genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Regulated expression of a foreign gene targeted to the ischaemic myocardium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

VEGF 165 Expressed by a Replication-Deficient Recombinant Adenovirus Vector Induces Angiogenesis In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302481

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15772688%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 January 2020

1039002884

0 references

1 reference